Top Story

Maximum intensity projections showing biodistribution of Cu-61 NODAGA-LM3 (146 MBq) in a patient with a metastatic non-functional NET of the pancreas G2 (Ki-67: 5%) with lymph node, hepatic, osseous, and peritoneal as well as ovarian metastases. PET performed a 1-hour, 3-hours, and 18-hours post-injection show high and prolonged tumor uptake and excellent image contrast, with low uptake in the liver, intestinal tract, and other non-target organs.
Nuclear Medicine
Novel SST2-PET tracer shows promise in patients with NETs
With a half-life of 3.3 hours, cyclotron-produced Cu-61 NODAGA-LM3 could allow delayed imaging and centralized distribution.
Featured
Prof. Dr. Konstantin Nikolaou, chairman of the Department of Diagnostic and Interventional Radiology at the University of Tübingen, and chair of the ESR's AI and Digital Technologies Committee is one of the most influential voices on AI governance in European radiology.
RöKo 2026
RöKo 2026: Nikolaou on AI policy, data gaps, and a prostate cancer paradox
Inflammatory Bowel Crohns
CT
4 CT signs help predict ischemia in small bowel obstruction
Latest News
The 2025 census report from the Royal College of Radiologists highlights the challenges facing services across the UK.
U.K. radiologist staffing lags EU peers, RCR census shows
June 25, 2026
Pet Scan Patient 400 (1)
PET/CT could improve margin assessment for breast tumors
June 19, 2026
Maskell Giles 2020 400
One conference, three lessons
June 18, 2026
Prostate Imaging
Single-fraction SBRT a valid option for localized prostate cancer
June 18, 2026
Cases of the Week
Check out our Cases of the Week!
32-year-old man with subacute left jaw pain
A 32-year-old man presented to clinic for subacute left “jaw pain.”
60-year-old man with penile and scrotal swelling
33-year-old woman with ADPKD and incidentally identified lesion
View All Cases
Maximum intensity projections showing biodistribution of Cu-61 NODAGA-LM3 (146 MBq) in a patient with a metastatic non-functional NET of the pancreas G2 (Ki-67: 5%) with lymph node, hepatic, osseous, and peritoneal as well as ovarian metastases. PET performed a 1-hour, 3-hours, and 18-hours post-injection show high and prolonged tumor uptake and excellent image contrast, with low uptake in the liver, intestinal tract, and other non-target organs.
Nuclear Medicine
Novel SST2-PET tracer shows promise in patients with NETs
Molecular Imaging
PET RANO gains visibility as neurotheranostics research advances
Molecular Imaging
As theranostics advances, access challenges remain across Europe
Molecular Imaging
Six European societies launch RLT Referral Pathways Project
Molecular Imaging
PET/CT could improve margin assessment for breast tumors
Hospitals across Europe, here in Katowice, Poland, are deploying AI tools in clinical workflows, but the regulatory infrastructure to oversee them is still catching up.
AI
One tool, many rulebooks: How the world is and isn't regulating medical AI
AI
The great AI debate: Expensive failure or vital prerequisite?
MRI
AI gives a boost to cardiac MRI risk prediction
Womens Imaging
AI may provide early breast cancer alerts from mammograms
Digital X-Ray
SERAM 2026: AI chest triage cuts referrals without raising CT use
Image2
Ultrasound
Canon Medical, Fraiya partner for AI prenatal ultrasound in Europe
Enterprise Imaging
Sectra signs enterprise imaging deal with German radiology group
Ultrasound
BrightHeart receives CE mark for prenatal ultrasound AI platform
Digital X-Ray
DRGEM wins CE certification for mobile DR system
Industry News
$9M grant invests in 'next generation' of CAA scientists
More from AuntMinnieEurope
Canon Medical, Fraiya partner for AI prenatal ultrasound in Europe
By AuntMinnieEurope.com staff writers
Imaging focuses on the mid-trimester anomaly scan.
June 26, 2026
Image2
Sectra signs enterprise imaging deal with German radiology group
By AuntMinnieEurope.com staff writers
Sectra has signed a 10-year enterprise imaging contract with MVZ MedDiagnost.
June 25, 2026
Sectra Rsna 2019 400
PET RANO gains visibility as neurotheranostics research advances
By Claudia Tschabuschnig
Standardized PET response assessment, emerging theranostic targets, and new strategies to overcome the blood-brain barrier are among the developments shaping neuro-oncology research.
June 24, 2026
Prof. Nathalie Albert of Ludwig Maximilian University of Munich, member of the EANM Oncology & Theranostics Committee and Scientific Chair of the NMN Symposium.
As theranostics advances, access challenges remain across Europe
By Claudia Tschabuschnig
Theranostics is advancing rapidly, but access remains uneven across Europe. According to Prof. Clemens Decristoforo, differences in national regulations and healthcare systems continue to influence patient access to innovative radiopharmaceuticals.
June 24, 2026
Prof. Clemens Decristoforo is a member of the EANM Policy & Regulatory Affairs Council and professor at the Department of Nuclear Medicine at the Medical University of Innsbruck.
BrightHeart receives CE mark for prenatal ultrasound AI platform
By AuntMinnieEurope.com staff writers
The CE mark follows an €11 million series A funding round.
June 24, 2026
Ai2
Six European societies launch RLT Referral Pathways Project
By Claudia Tschabuschnig
Radioligand therapy has proven itself clinically for advanced prostate cancer. What hasn't caught up is Europe's healthcare infrastructure.
June 23, 2026
Radiology and nuclear medicine are converging on clinical audit and quality frameworks across Europe.
DRGEM wins CE certification for mobile DR system
By AuntMinnie.com staff writers
The certification follows U.S. Food and Drug Administration clearance for Raymo in May.
June 22, 2026
Approval
$9M grant invests in 'next generation' of CAA scientists
By AuntMinnie.com staff writers
Project will combine advanced brain imaging with new molecular biomarkers and innovative experimental models.
June 19, 2026
Dollars Pile
Coreline Soft, Mint Medical partner on AI-enabled lung cancer screening
By AuntMinnie.com staff writers
Partnership initially focuses on Germany.
June 19, 2026
Business Handshake Intelligence Sm
Canon unveils Aplio me X ultrasound system at Euroson 2026
By AuntMinnieEurope.com staff writers
Canon Medical Systems unveiled its Aplio me X diagnostic ultrasound system at Euroson 2026.
June 18, 2026
Aplio me X ultrasound system
WHO: Europe's healthcare systems face "permacrisis"
By Claudia Tschabuschnig
Overlapping shortages, an aging population, and a workforce "voting with its feet" -- "permacrisis," that's how WHO Europe described the state of healthcare on the continent at the inaugural UEMS Congress in Leuven.
June 18, 2026
'We are no longer preparing for crises. We are actively navigating an era of permanent, overlapping disruptions, the convergence of rapid climate change, demographic shifts, systemic economic uncertainty, and a critical healthcare workforce means that traditional boundaries of healthcare are obsolete,' says Pavlos Theodorakis, senior health policy advisor at the WHO European Office.
German MRI concept aims to transform pediatric imaging
By Claudia Tschabuschnig
Why pediatric MRI still means anesthesia for too many children and how the field is trying to change that.
June 17, 2026
As part of the KidsMRI project, children are to be introduced to the examination using age-appropriate training and support concepts, with the aim of enabling MRI scans to be performed more often without anesthesia in the future.